Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

CSL Seqirus

Private

Global influenza vaccine business of CSL Limited, with manufacturing across three continents; being separated into a standalone company as part of CSL's restructuring.

Company Info

Sector:Vaccines
Headquarters:Maidenhead, United Kingdom
Founded:2015

Clinical Development Pipeline

Flucelvax Quadrivalent

Target: Influenza A and B
Seasonal influenza prevention
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Afluria Quadrivalent

Target: Influenza A and B
Seasonal influenza prevention
Preclinical
Phase 1
Phase 2
Phase 3
Approved

AUDENZ

Target: Influenza A and B (MF59-adjuvanted)
Seasonal influenza prevention in adults aged 65 and older
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Careers & Job Openings

See all open roles

All
Maidenhead, UK
Apply Now →